MEI PHARMA INC (MEIP) Stock News
NASDAQ:MEIP - Nasdaq - US55279B3015 - Common Stock - Currency: USD
MEIP Latest News, Press Relases and Analysis
MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position
MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week.
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.
MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips MEI Pharma (NASDAQ:MEIP) just reported results for the third quarter of 2024.ME...
MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024
MEIP stock results show that MEI Pharma beat analyst estimates for earnings per share the third quarter of 2024.
MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position
MEI Pharma Reports Fiscal Year End 2024 Cash Position
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
MEI Pharma to Consider Strategic Alternatives
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights
MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum
MEI Pharma files for $100M mixed shelf (NASDAQ:MEIP)
MEI Pharma files prospectus for mixed securities shelf offering of up to $100M.
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights
MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
MEI Pharma to Present at the Stifel 2023 Healthcare Conference
MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock
MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
MEI Pharma Recommends Stockholders Not to Consent
MEI Pharma Adopts Limited-Duration Stockholder Rights Plan
Infinity Pharmaceuticals reportedly files for Chapter 11 (OTCMKTS:INFI)
Infinity Pharmaceuticals (INFI) has reportedly filed for bankruptcy in the wake of the termination of its merger deal with MEI Pharma.
Mentions: INFI
MEI Pharma Issues Statement Regarding Anson and Cable Car’s Opportunistic Actions